DCTH NEWS!! gets special FDA designation for therapy Delcath shares pop on special FDA designation for chemotherapy treatment for liver cancer.
BREAK .40 with volume could be .99 cents or 150% from breakout
THE BIG PICTURE: Delcath is a specialty-drug and medical-device company focused on cancer treatments. It makes a catheter system that treats cancer by delivering high doses of chemotherapy drugs directly to the liver while controlling exposure to the rest of the body.
The FDA is reviewing several uses of the technology, including treatment of inoperable ocular melanoma, a cancer of the eye that can spread to the liver. The system is available in Europe for that use under the name Chemosat.
Note 1: Please alert the board of any stock crossing the 20,50,20dma’s on daily or weekly chart.
(link back for more charts) Note 2: Please do an 8x34 chart on the stock; the 8x34 cross is the initial reversal sign of most stocks. Use the link below, just replace the ticker symbol. Post on the board when a stock crosses the 8DMA or the 34DMA and when the 8x34 cross is about to occur.
8x34 cross in the making, look at Full Sto, and CMF indicators. just replace the ticker with your TICKER
News 
Market Data 
Discover 
AI
